Skip to main content
. 2024 May 30;26(2):290–299. doi: 10.5853/jos.2024.00458

Table 1.

Baseline characteristics, metrics, and outcomes of patients with PCA occlusion treated with EVT with or without IVT versus IVT alone

All (n=724) EVT+/-IVT (n=400) IVT (n=324) P Missing data
Baseline characteristics
 Age (yr) 74 (64–82) 74 (64–82) 75 (65–82) 0.23 0/0/0
 Male sex 418 (57.7) 228 (57.0) 190 (58.6) 0.71 0/0/0
 Pre-stroke mRS 0 (0–1) 0 (0–1) 0 (0–1) 0.39 0/0/0
  0 458 (63.3) 257 (64.3) 201 (62.0) 0.40 0/0/0
  1 132 (18.2) 76 (19.0) 56 (17.3) - -
  2 72 (9.9) 39 (9.8) 33 (10.2) - -
  3 62 (8.6) 28 (7.0) 34 (10.5) - -
 Hypertension 539 (74.4) 305 (76.3) 234 (72.2) 0.23 0/0/0
 Diabetes 166 (22.9) 92 (23.0) 74 (22.8) 1.00 0/0/0
 Hyperlipidemia 330 (45.7) 171 (42.9) 159 (49.2) 0.10 2/1/1
 Atrial fibrillation 219 (30.2) 131 (32.8) 88 (27.2) 0.11 0/0/0
 Current smoker 104 (16.1) 51 (15.0) 53 (17.3) 0.46 78/61/17
 Prior stroke 106 (14.9) 50 (12.9) 56 (17.3) 0.11 13-12-1
 Coronary heart disease 122 (17.3) 64 (16.7) 58 (17.9) 0.69 17/17/0
 Peripheral artery disease 39 (6.2) 18 (5.5) 21 (6.9) 0.51 90/72/18
 Dialysis 27 (4.2) 16 (4.8) 11 (3.5) 0.44 75/68/7
 Oral anticoagulation 87 (12.4) 64 (16.8) 23 (7.2) <0.01* 23/18/5
 Statin 232 (34.6) 117 (33.0) 115 (36.4) 0.37 53/45/8
 NIHSS on admission 7 (4–11) 8 (5–12) 6 (3–10) <0.01* 0/0/0
 Baseline visual field defect 449 (70.0) 228 (69.3) 221 (70.8) 0.73 83/71/12
 SBP (mm Hg) 158 (140–176) 159 (138–175) 157 (141–176) 0.80 92/73/19
 DBP (mm Hg) 85 (75–97) 84 (74–97) 86 (75–98) 0.31 97/77/20
Baseline imaging
 Imaging modality
  CT 656 (92.0) 349 (89.7) 307 (94.8) 0.02* 11/11/0
  MRI 106 (14.9) 53 (13.6) 53 (16.4) 0.34 11/11/0
  Perfusion 437 (61.3) 230 (59.1) 207 (63.9) 0.22 11/11/0
 pc-ASPECTS 10 (9–10) 10 (9–10) 10 (9–10) 0.04* 0/0/0
 Clot location <0.01* 0/0/0
  P1 318 (43.9) 217 (54.3) 101 (31.2) - -
  P2 350 (48.3) 159 (39.8) 191 (59.0) - -
  P3 or P4 44 (6.1) 13 (3.3) 31 (9.6) - -
  PCom 5 (0.7) 4 (1.0) 1 (0.3) - -
  Bilateral 7 (1.0) 7 (1.8) 0 - -
 Perfusion mismatch >20% 317 (91.6) 161 (94.2) 156 (89.1) 0.12 378/229/149
Treatment factors
 IVT 488 (67.4) 164 (41.0) 324 (100) <0.01* 0/0/0
 Onset-to-treatment time (h) 2.9 (1.8–4.7) 3.8 (2.4–7.2) 2.3 (1.5–3.3) <0.01* 59/54/5
 Time to treatment ≤4.5 h 488 (73.4) 206 (59.5) 282 (88.4) <0.01* 59/54/5
 Wake-up stroke 138 (19.9) 106 (27.3) 32 (10.4) <0.01* 29/12/17
 First-pass EVT technique 54
  SR - 44 (12.7) - - -
  Aspiration - 178 (51.4) - - -
  Combined SR and aspiration - 114 (32.9) - - -
  Intra-arterial thrombolysis - 5 (1.4) - - -
  Other - 5 (1.4) - - -
 No. of passes - 1 (1–2) - - 18
 Recanalization 3
  TICI 0-2a - 81 (20.4) - - -
  TICI 2b-3 - 316 (79.6) - - -
Etiology 0.04* 0/0/0
 Large artery atherosclerosis 126 (17.4) 83 (20.8) 43 (13.3) - -
 Cardioembolism 285 (39.4) 148 (37.0) 137 (42.3) - -
 Small vessel disease 19 (2.6) 7 (1.8) 12 (3.7) - -
 Other 54 (7.5) 28 (7.0) 26 (8.0) - -
 Undetermined 240 (33.1) 134 (33.5) 106 (32.7) - -
Visual field recovery 0.62 287/156/131
 Complete 96 (59.3) 46 (63.9) 50 (55.6) - -
 Partial 12 (7.4) 5 (6.9) 7 (7.8) - -
 None 35 (21.6) 15 (20.8) 20 (22.2) - -
 Worse 19 (11.7) 6 (8.3) 13 (14.4) - -

Values are presented as median (interquartile range) or n (%).

PCA, posterior cerebral artery; EVT, endovascular thrombectomy; IVT, intravenous thrombolysis; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure; DBP, diastolic blood pressure; CT, computed tomography; MRI, magnetic resonance imaging; pc-ASPECTS, posterior circulation Acute Stroke Prognosis Early CT Score; PCom, posterior communicating artery; SR, stent retriever; TICI, Thrombolysis In Cerebral Infarction.

*

P<0.05;

The distribution was higher in the IVT group;

Of the 449 patients with visual field defect on the baseline.